company background image
688166 logo

BrightGene Bio-Medical Technology SHSE:688166 Stock Report

Last Price

CN¥31.16

Market Cap

CN¥13.2b

7D

5.3%

1Y

48.5%

Updated

23 Jul, 2024

Data

Company Financials +

BrightGene Bio-Medical Technology Co., Ltd.

SHSE:688166 Stock Report

Market Cap: CN¥13.2b

688166 Stock Overview

A pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China.

688166 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance2/6
Financial Health3/6
Dividends0/6

BrightGene Bio-Medical Technology Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BrightGene Bio-Medical Technology
Historical stock prices
Current Share PriceCN¥31.16
52 Week HighCN¥46.88
52 Week LowCN¥17.81
Beta0.26
11 Month Change-13.88%
3 Month Change14.18%
1 Year Change48.45%
33 Year Change-12.96%
5 Year Changen/a
Change since IPO1.80%

Recent News & Updates

BrightGene Bio-Medical Technology Co., Ltd.'s (SHSE:688166) 47% Share Price Surge Not Quite Adding Up

May 21
BrightGene Bio-Medical Technology Co., Ltd.'s (SHSE:688166) 47% Share Price Surge Not Quite Adding Up

Recent updates

BrightGene Bio-Medical Technology Co., Ltd.'s (SHSE:688166) 47% Share Price Surge Not Quite Adding Up

May 21
BrightGene Bio-Medical Technology Co., Ltd.'s (SHSE:688166) 47% Share Price Surge Not Quite Adding Up

BrightGene Bio-Medical Technology Co., Ltd. (SHSE:688166) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Mar 01
BrightGene Bio-Medical Technology Co., Ltd. (SHSE:688166) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Shareholder Returns

688166CN PharmaceuticalsCN Market
7D5.3%3.0%0.5%
1Y48.5%-13.4%-16.6%

Return vs Industry: 688166 exceeded the CN Pharmaceuticals industry which returned -13.4% over the past year.

Return vs Market: 688166 exceeded the CN Market which returned -16.6% over the past year.

Price Volatility

Is 688166's price volatile compared to industry and market?
688166 volatility
688166 Average Weekly Movement8.9%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 688166 has not had significant price volatility in the past 3 months.

Volatility Over Time: 688166's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20011,155Jiandong Yuanwww.bright-gene.com

BrightGene Bio-Medical Technology Co., Ltd., a pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China. The company offers Eribulin mesylate injection, Voriconazole for injection, Entecavir tablets, Oseltamivir phosphate capsule and dry suspension, Agatroban injection, Mikafungin sodium for injection, Fondaparinux sodium injection, and Caspofungin acetate for injection. It also provides antitumor, antibodies drug conjugate, anti-infection, angiography, gynecology, cardiovascular, cerebrovascular, iron supplement, digestion, and other APIs and intermediates.

BrightGene Bio-Medical Technology Co., Ltd. Fundamentals Summary

How do BrightGene Bio-Medical Technology's earnings and revenue compare to its market cap?
688166 fundamental statistics
Market capCN¥13.15b
Earnings (TTM)CN¥195.77m
Revenue (TTM)CN¥1.21b

67.2x

P/E Ratio

10.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688166 income statement (TTM)
RevenueCN¥1.21b
Cost of RevenueCN¥563.20m
Gross ProfitCN¥651.51m
Other ExpensesCN¥455.74m
EarningsCN¥195.77m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 24, 2024

Earnings per share (EPS)0.46
Gross Margin53.63%
Net Profit Margin16.12%
Debt/Equity Ratio89.3%

How did 688166 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

21%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.